Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cindunistat in Symptomatic Knee Osteoarthritis
NCT01438918Phase 3Withdrawn
- Sponsor
- Pfizer
- Start
- Mar 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cindunistat in osteoarthritis (OA), sponsored by Pfizer. Planned start Mar 2012; status: withdrawn.
02
Drugs
cindunistat
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01438918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438918.